1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I: Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004, 55-64.
2. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I: Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004, 21-27.
3. Kato I, Zeleniuch-Jacquotte A, Toniolo PG, Akhmedkhanov A, Koenig K, Shore RE: Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study. J Public Health Med. 2000, 22: 155-160. 10.1093/pubmed/22.2.155.
4. Licinio J, Wong ML: Depression, antidepressants and suicidality: a critical appraisal. Nat Rev Drug Discov. 2005, 4: 165-171. 10.1038/nrd1634.
5. Nardi DA, Barrett S: Potential effects of antidepressant agents on the growth and development of children and adolescents. J Psychosoc Nurs Ment Health Serv. 2005, 43: 22-35.